Case reports highlight the diagnosis of combined small cell lung cancer in two patients, suggesting early surgical resection is vital.
Combined Small Cell Lung Cancer (C-SCLC) is defined by the World Health Organization (WHO) as a combination of Small Cell Lung Cancer (SCLC) and other components, which may include any type of Non-Small Cell Lung Cancer (NSCLC). It is a relatively rare type of lung cancer, with an incidence ranging from 2% to 28%, and its incidence is on the rise. We report two cases of combined small cell lung cancer (C-SCLC) diagnosed by postoperative pathology following thoracoscopic left upper lobectomy at our hospital. One case was small cell carcinoma combined with squamous cell carcinoma (95% SCLC + 5% SCC), while the other was small cell carcinoma combined with large cell carcinoma. Both patients were male with a history of heavy smoking. Postoperatively, they received adjuvant chemotherapy combined with immunotherapy and surgery alone, respectively. No recurrence was observed during follow-up. This paper, in conjunction with a literature review, discusses the clinical and pathological features, diagnosis, potential molecular markers, treatment, and prognosis of C-SCLC. We emphasize the importance of early surgical resection and individualized comprehensive treatment, aiming to provide clinical reference for the diagnosis and management of this rare type of lung cancer.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: